Both excessive ROS production and COX-2 activation led to the progress of systematic inflammation, insulin resistance, and increased oxidative stress (41–43), contributing to an elevated risk of obesity (44, 45). Here, PTGS2 is linked to obesity due to melanocortin 4 receptor deficiency.